Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients
- 30 April 2001
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 37 (4) , 758-765
- https://doi.org/10.1016/s0272-6386(01)80125-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapyKidney International, 1999
- Pathophysiology and Clinical Importance of Hyperhomocysteinemia: Clinical Intervention StudiesMineral and Electrolyte Metabolism, 1999
- Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipientsKidney International, 1999
- Measurement and Use of Total Plasma HomocysteineAmerican Journal of Human Genetics, 1998
- A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme ActivityMolecular Genetics and Metabolism, 1998
- 5-Formyltetrahydrofolate Regulates Homocysteine Remethylation in Human NeuroblastomaJournal of Biological Chemistry, 1997
- High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patientsKidney International, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Plasma folate conjugase activities and folate concentrations in patients receiving hemodialysisThe Journal of Nutritional Biochemistry, 1994
- Mechanism of mammalian cobalamin-dependent methionine biosynthesisBiochemistry, 1971